Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Psychiatry/Psychology | Neurology | Family Medicine
Depression Clinical Trials
A listing of Depression medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : The University of Alabama at Birmingham, Office of Psychiatric Research
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Birmingham : The University of Alabama at Birmingham, Office of Psychiatric Research
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Birmingham :
A Study of Ketamine in Patients With Treatment-resistant Depression
Birmingham :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Birmingham :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
View More »
Birmingham : Birmingham Research Group Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Birmingham : Birmingham Psychiatry Pharmaceutical Studies, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Birmingham : UAB
Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation
Birmingham : Teva Investigational Site 225
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Dothan : Dothan Behavioral Medicine Clinic
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Dothan : Harmonex
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Dothan : Harmonex
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Dothan : Dothan Behavioral Medicine Clinic
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Arizona
Tucson : Radiant Research - Tucson
New Clinical Research Study for Depression
View More »
Phoenix : Dedicated Clinical Research
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Phoenix : Dedicated Clinical Research
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Scottsdale : ResearchOne, Inc.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Tucson : Center for Advanced Improvement
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Tucson : University of Arizona Clinical and Translational Science Center (CATS)
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Tucson : University of Arizona College of Medicine Department of Psychiatry
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Tucson : Genova Clinical Research
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Tucson : Center for Advanced Improvement
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Tucson : University of Arizona College of Medicine Department of Psychiatry
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Tucson : University of Arizona Clinical and Translational Science Center
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Tucson :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Tucson :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Arkansas
Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials, P.A.
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials, P.A.
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Little Rock :
A Study of Ketamine in Patients With Treatment-resistant Depression
Little Rock : K&S Professional Research Services, LLC
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Little Rock : K&S Professional Research Services, LLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
View More »
Little Rock :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials, P.A.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Little Rock :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Little Rock : Call for Information (Investigational Site 0424)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
California
Arcadia : Pacific Clinical Research Medical Group
Depressed? Not Happy With Your Antidepressant?
Arcadia : Pacific Clinical Research Medical Group
Depressed? Sad? Unmotivated?
Cerritos : Comprehensive Clinical Development - Cerritos, CA
Depression ITN# 11336
Colton : SHANTI Clinical Trials
Depression
Encino : Pharmacology Research Institute, Encino
Are you currently taking an antidepressant such as Celexa, Paxil or Zoloft and experiencing sexual side effects?
Encino : Pharmacology Research Institute, Encino
Studies with investigational antidepressant medications for men and women 18 years and older.
Imperial : Sun Valley Research Center
Have you been diagnosed with Depression and your current medication is not working as it should?
Los Alamitos : Pharmacology Research Institute, Los Alamitos
Phase 2, Double-Blind, Placebo-Controlled, Randomized Withdrawal, Parallel Efficacy and Safety Study of GLYX-13 in Subjects with Inadequate/Partial Response to Antidepressants During the Current Episode of Major Depressive Disorder
Los Alamitos : Pharmacology Research Institute, Los Alamitos
Studies with investigational antidepressant medications for men and women 18 years and older.
Newport Beach : Pharmacology Research Institute, Newport Beach
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients with Major Depressive Disorder
Newport Beach : Pharmacology Research Institute, Newport Beach
Are you currently taking an antidepressant such as Celexa, Paxil or Zoloft and experiencing sexual side effects?
Newport Beach : Pharmacology Research Institute, Newport Beach
Studies with investigational antidepressant medications for men and women 18 years and older.
Orange : Pacific Clinical Research Medical Group
Being a Kid is Hard Enough without having to deal with DEPRESSION
Orange : Pacific Clinical Research Medical Group
Depressed? Clinical Research Trial for Depression Now Enrolling in Orange, CA.
Sherman Oaks : Schuster Medical Research Institute
Clinical Research Study of an investigational medication for treatment resistant Major Depressive Disorder
Sherman Oaks : California Neuroscience Research Medical Group, Inc.
Clinical research study of an investigational medication vs. placebo added to a
standard antidepressant treatment in persons with Major Depression.
Sherman Oaks : Schuster Medical Research Institute
On An Antidepressant but STILL NOT Feeling Better?
Sherman Oaks : Schuster Medical Research Institute
Research study of an investigational medication for Major Depression Disorder with partial response to antidepressants SSRI
Upland : Pacific Clinical Research Medical Group
Depressed?
Upland : Pacific Clinical Research Medical Group, Upland CA
Depressed? Sad? Clinical Trial for Depression Now Enrolling in Upland, CA
Upland : Pacific Clinical Research Medical Group
Depressed? Clinical Research Trial for Depression Now Enrolling in Upland, CA
Wildomar : Elite Clinical Trials, Inc.
Are you depressed? Do you feel like you just can't get beyond your depression?
View More »
Anaheim : South Coast Clinical Trials, Inc
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Anaheim :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Anaheim : South Coast Clinical Trials
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Arcadia : Pacific Clinical Research Medical Group
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Beverly Hills :
A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Carson : AV Institue, Inc. Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Cerritos :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Chino :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Chino : Catalina Research Institute, Llc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Chino : Catalina Research Institute, LLC
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Colton : Shanti Clinical Trials
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Costa Mesa : ATP Clinical Research, Incorporated
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Costa Mesa : ATP Clinical Research, Incorporated
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Costa Mesa : ATP Clinical Research, Inc.
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Costa Mesa :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Costa Mesa :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Costa Mesa : ATP Clinical Research, Inc.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Costa Mesa :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Costa Mesa : Clinical Innovation, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Downey : Diligent Clinical Trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Downey : Diligent Clinical Trials
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Encino :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Encino : Pharmacology Research Institute
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Escondido : Synergy Clinical Research Center
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Escondido :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Escondido : Synergy Clinical Reserach Center of Escondido
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Garden Grove :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Garden Grove : Collaborative Neuroscience Network, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Garden Grove :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Garden Grove : Call for Information (Investigational Site 0042)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
Garden Grove : Collaborative Neuroscience Network, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Glendale : Behavioral Research Specialists, LLC
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Glendale : California Clinical Trials Medical Group
A Multiple Ascending Oral Dose Evaluation of the Safety, Tolerability, and Pharmacokinetics of DSP-1053 and Its Metabolites in Healthy Subjects and in Subjects With Major Depressive Disorder
Glendale : Behavioral Research Specialists, LLC
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Glendale :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Glendale : Behavioral Research Specialists, Llc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Glendale : California Clinical Trials
Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects
Imperial : Sun Valley Research Center
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Imperial : Sun Valley Research Center
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Imperial :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Irvine : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Irvine :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Irvine : University of California, Irvine Child Development Center Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Irvine : Irvine Center for Clinical Research
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
La Habra : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
La Habra : Omega Clinical Trials
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Los Alamitos : Pharmacology Research Institute
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Los Angeles :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Los Angeles : University of California (UCLA)
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Los Angeles : Provate Practice of Andrew Leuchter, MD
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Los Angeles : UCLA Depression Research & Clinic Program Updated
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
National City : Synergy Clinical Research Center
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
National City : Synergy Clinical Research Center
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
National City : US001
Efficacy and Safety of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Newport Beach :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Newport Beach : Pharmacology Research Institute
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Norwalk :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Oakland : Pacific Research Partners, LLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Oakland :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Oceanside :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Oceanside :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Oceanside : North County Clinical Research Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Oceanside :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Orange : Pacific Clinical Research Medical Group
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Orange : Pacific Clinical Research Medical Group
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Orange :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Orange : Pacific Clinical Research Medical Group
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Palo Alto :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Palo Alto : Stanford -VA Palo Alto Health Care System
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
Palo Alto : Stanford -VA Palo Alto Health Care System
Major Depressive Disorder With Mixed Features - Extension
Paramount :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Paramount :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Pasadena : Pasadena Research Institute, LLC Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Redlands : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Redlands : Anderson Clinical Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Redlands : Anderson Clinical Research
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Redlands : Call for Information (Investigational Site 0027)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
Riverside :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
San Bernardino : Breakthrough Clinical Trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
San Bernardino : BreakThrough Clinical Trials, LLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
San Bernardino :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
San Diego : South Bay Research Center
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
San Diego :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
San Diego : Clinical Innovations, Inc. Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
San Diego : Affiliated Research Institute Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
San Diego : Sharp Mesa Vista Hospital Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
San Diego : Pacific Research Network
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
San Diego : Sharp Mesa Vista Hospital
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
San Diego : Artemis Institute For Clinical Research
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
San Diego : California Neuropsychopharmacology Clinical
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
San Diego : Affiliated Research Institute
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
San Diego :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
San Diego : Artemis Institute for Clinical Research
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
San Diego : PCSD - Feighner Research
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
San Diego : UCSD Medical Center Updated
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Santa Ana : Neuropsychiatric Research Center of Orange County
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Santa Ana : Neuropsychiatric Research Center of Orange County
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Santa Ana :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Santa Ana : Neuropsychiatric Research Center Of Orange County
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Santa Ana :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Santa Ana : Neuropsychiatric Research Center of Orange County
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Sherman Oaks : Schuster Medical Research Institute
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Sherman Oaks : California Neuroscience Research Medical Group, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Sherman Oaks : Call for Information (Investigational Site 0422)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
Sherman Oaks : California Neuroscience Research Medical Group, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Sherman Oaks : Teva Investigational Site 295
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Stanford : Stanford University
International Study to Predict Optimised Treatment - in Depression
Stanford : Veteran Affairs/Stanford University
International Study to Predict Optimised Treatment - in Depression
Temecula : Teva Investigational Site 122
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Torrance :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Upland : Pacific Clinical Research Medical Group
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Victorville :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Wildomar : Elite Clinical Trials, Incorporated
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Wildomar : Elite Clinical Trials, Incorporated
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Wildomar :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Wildomar :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Colorado
Denver : Radiant Research - Denver
Clinical Research for Depression
Denver : Radiant Research - Denver
Research Study for Depression
Denver : Radiant Research - Denver
Still Depressed?
View More »
Aurora : Children's Hospital Colorado
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Aurora : The Children's Hospital
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Centennial :
A Study of Ketamine in Patients With Treatment-resistant Depression
Colorado Springs : MCB Clinical Research Centers
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Colorado Springs :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Denver : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Denver :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Denver :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Denver : Western Affiliated Research Institute
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Denver : Radiant Research, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Denver : Western Affiliated Research Institute
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Connecticut
Cromwell : Connecticut Clinical Research
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Cromwell : Connecticut Clinical Research
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Farmington : University of Connecticut Health Center
Study of Technology-assisted Treatment of Adolescent Depression
Hamden : Geriatric and Adult Psychiatry, LLC Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Hartford :
A Study of Ketamine in Patients With Treatment-resistant Depression
View More »
Hartford : Institute of Living
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Hartford : Hartford Hospital Institute of Living Updated
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
New Britain : The Hospital of Central Connecticut, Psychiatry & Behavioral Health Research
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
New Haven :
A Study of Ketamine in Patients With Treatment-resistant Depression
Norwalk :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Norwalk :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Norwich :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Norwich : Comprehensive Psychiatric Care
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Delaware
Wilmington : Christiana Care Health Services
Patient-Centered Depression Care for African Americans
District of Columbia
Washington :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Washington :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Washington : US003
Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder
Florida
Hallandale Beach : MD Clinical Updated
Are you experiencing depression symptoms?
Maitland : Florida Clinical Research Center - Orlando/Maitland
Are you Depressed?
Maitland : Florida Clinical Research Center - Orlando/Maitland
Depression getting you down?
Pinellas Park : Radiant Research - St. Petersburg
Research Opportunity (Heat Patch)
St. Petersburg : Comprehensive Clinical Development - St. Petersburg, FL
Depression ITN# 11980
St. Petersburg : Comprehensive Clinical Development - St. Petersburg, FL
Depression ITN# 12040
St. Petersburg : Comprehensive Clinical Development - St. Petersburg, FL
Depression ITN# 12040
St. Petersburg : Comprehensive Clinical Development - St. Petersburg, FL
Depression ITN# 12040
View More »
Bradenton : Florida Clinical Research Center, LLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Brooksville : Meridien Research
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Clearwater : Innovative Research of West Florida, Inc.
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Coral Gables :
A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Coral Springs :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Coral Springs :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Coral Springs : CNS Clinical Research Group Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Destin : SJS Clinical Research
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Destin : SJS Clinical Research, Inc.
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Fort Myers : Gulfcoast Clinical Research Center
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Gainesville : Sarkis Clinical Trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Gainesville :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Gainesville :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Gainesville : Sarkis Clinical Trials
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Hallandale Beach : Call for Information (Investigational Site 0036)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
Hialeah : Amedica Research Institute, Incorporated
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Hialeah : Amedica Research Institute, Incorporated
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Hollywood : Segal Institute for Clinical Research
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Jacksonville : Clinical Neuroscience Solutions, Inc.
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Jacksonville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Jacksonville : Clinical Neuroscience Solutions, Inc.
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Jacksonville :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Jacksonville : Clinical Neuroscience Solutions, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Jacksonville : Amit Vijapura
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Jacksonville : Clinical Neuroscience Solutions, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Jacksonville : Private Practice - Amit Vijapura MD
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Jacksonville Beach : Teva Investigational Site 606
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Juno Beach : Advanced Mental Health Care Inc. - Juno Beach
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Kissimmee : Accurate Clinical Trials
Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
Lake City : Psychiatric Associates
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Lauderhill :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Lauderhill :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Lauderhill : Teva Investigational Site 127
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Leesburg : Compass Research, LLC: North Clinic
Efficacy of Electronic Cognitive Behavioral Therapy Application to Treat Major Depressive Disorder
Maitland : Florida Clinical Research Center, LLC. Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Melbourne :
A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Miami : AMB Research Center
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Miami :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Miami : University of Miami
International Study to Predict Optimised Treatment - in Depression
Miami : Miami Jewish Health System
Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
Miramar : Comprehensive Neuroscience, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
New Port Richey : Suncoast Clinical Research Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
North Miami :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
North Miami : Scientific Clinical Research, Inc.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
North Miami : Fideltiy Clinical Research, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
North Miami : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Oakland Park :
A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Orange City :
A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Orange City :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Orlando : Ali A. Kashfi, MD
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Orlando : Clinical Neuroscience Solutions Incorporated
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Orlando : Clinical Neuroscience Solutions Incorporated
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Orlando : Ali A. Kashfi, MD
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Orlando :
A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Orlando :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Orlando : US008
Efficacy and Safety of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Orlando : Compass Research, LLC Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Orlando : Clinical Neuroscience Solutions, Inc.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Orlando :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Orlando : Clinical Neuroscience Solutions, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Orlando : Compass Research, Llc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Orlando : Ali A. Kashfi, MD, PA
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Royal Palm Beach : Advanced Mental Health Care Inc. - Royal Palm Beach
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Sanford :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
St. Petersburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
St. Petersburg : Meridien Research Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
St. Petersburg : Comprehensive NeuroScience, Inc.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
St. Petersburg :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
St. Petersburg : Comprehensive Clinical Development, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Tampa : Meridien Research
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Tampa :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Tampa : Stedman Clinical Trials Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
University Park : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
West Palm Beach :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
West Palm Beach : Janus Center for Psychiatric Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
West Palm Beach :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
West Palm Beach : Janus Center For Psychiatric Research
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Winter Haven : Clinical Research of Central Florida
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Winter Park : Kolin Research Group
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Winter Park : Winter Park Memorial Hospital
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Winter Park : Kolin Research Group
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Winter Park : Winter Park Memorial Hospital
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Winter Park : Kolin Research Group
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Georgia
Atlanta : Mood and Anxiety Disorders Program of Emory University
Have you been feeling sad or down nearly every day over the past month?
Atlanta : Mood and Anxiety Disorders Program of Emory University
How are you feeling?
Atlanta : Comprehensive Clinical Development - Atlanta, GA
Still Feeling Depressed? ITN# 11318
Stockbridge : Mood and Anxiety Disorders Program of Emory University
Have you been feeling sad or down nearly every day over the past month?
View More »
Atlanta : Atlanta Center for Medical Research
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Atlanta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Atlanta : Atlanta Center for Medical Research
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Atlanta :
A Study of Ketamine in Patients With Treatment-resistant Depression
Atlanta : Atlanta Center for Medical Research
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Atlanta :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Atlanta :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Atlanta :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Atlanta : Atlanta Center for Medical Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Atlanta : Atlanta Institute of Medicine & Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Atlanta : Comprehensive Neuroscience, Inc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Atlanta : Emory University
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Atlanta :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Atlanta : Emory University
Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression
Atlanta : Teva Investigational Site 205
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Columbus : Medical Research and Health Education Foundation, Inc.
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Marietta : Northwest Behavioral Research Center
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Marietta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Marietta : Northwest Behavioral Research Center/Northwest Behavioral Medicine
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Roswell :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Smyrna : Institute for Behavioral Medicine, LLC
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Smyrna : Institute for Behavioral Medicine, LLC
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Smyrna :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Smyrna : Carman Research Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Smyrna : Carman Research
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Smyrna : Call for Information (Investigational Site 0028)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
Smyrna : Institute for Behavioral Medicine, LLC
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Illinois
Chicago : Rush University Medical Center - Treatment Research Center
Do you suffer from Depression?
Chicago : Rush University Medical Center - Treatment Research Center
Preventing the Recurrence of Depression in Bipolar Disorder
Chicago : Chicago Research Center, Inc
This research will evaluate the safety, tolerability and efficacy of an experimental drug, Levomilnacipran, sustained release (SR) compared to placebo (inactive substance) in the potential treatment of depression in people with Major Depressive Disorder.
Skokie : Psychiatric Medicine Associates/John Zajecka, M.D.
Depression Research Study
Skokie : Psychiatric Medicine Associates/John Zajecka, M.D.
Depression Research Study for adults who are currently taking an antidepressant but still experiencing some symptoms of depression
Skokie : Rush University Medical Center - Treatment Research Center
Depression Study. A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo- Controlled, Phase III, Efficacy and Safety Study of 3 Fixed Dose Groups of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressant in Patients with Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy
View More »
Chicago :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Chicago :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Chicago : Rush Medical College
Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression
Chicago : Treatment Research Center, Rush University Medical Center
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Chicago : TMS Specialists Chicago Updated
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Hoffman Estates :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Hoffman Estates : Alexian Brothers Center for Psychiatric Research
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Joliet :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Libertyville : Capstone Clinical Research
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Libertyville : Capstone Clinical Research
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Libertyville :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Naperville : AMR-Baber Research Inc.
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Naperville : AMR-Baber Research Inc.
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Naperville :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Oak Brook : American Medical Research, Inc. Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Oak Brook :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Oak Brook :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Skokie :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Skokie : Psychiatric Medicine Associates, LLC
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Vernon Hills : Sleep and Behavior Medicine Institute
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Indiana
Indianapolis : The Davis Clinic Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Indianapolis :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Lafayette : Alpine Clinic
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Lafayette : Teva Investigational Site 600
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Newburgh : Pedia Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
View More »
Terre Haute : Clinco
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Terre Haute : Clinco
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Terre Haute : Clinco
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Valparaiso : Northwest Indiana Center for Clinical Research Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Kansas
Wichita : Via Christi Research
ARTDeCo: Adding Study Drug to Current Antidepressant Not Adequately Treating Major Depressive Disorder
View More »
Overland Park : Psychiatric Associates
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Overland Park : Psychiatric Associates
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Prairie Village :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Prairie Village : Clinical Trials Technology, Inc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Prairie Village : Call for Information (Investigational Site 0041)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
Prairie Village : Clinical Trials Technology, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Prairie Village : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Wichita : Heartland Research Associates, LLC
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Wichita : Heartland Research Associates
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Wichita : US004
Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder
Wichita : University of Kansas
Phase 2, Double-Blind, Placebo Controlled, Randomized Withdrawal, Parallel Efficacy and Safety Study of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants During the Current Episode of Major Depressive Disorder
Kentucky
Edgewood : OtriMed Clinical Research
Adult Major Depressive Disorder Clinical Trial
Lexington : Kentucky Medical Research
Depression
View More »
Florence : MCM Clinical Research LLC Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Lexington : Central Kentucky Research Associates, Inc.
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Owensboro : Pedia Research, LLC
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Louisiana
Lake Charles : Lake Charles Clinical Trials
Study of Cariprazine in Participants with Bipolar Depression
View More »
Lake Charles : Lake Charles Clinical Trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Lake Charles : Lake Charles Clinical Trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Lake Charles :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
New Orleans : James G. Barbee, Md, Llc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
New Orleans : Call for Information (Investigational Site 0407)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
Shreveport :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Shreveport :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Shreveport : Louisiana Clinical Research, LLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Shreveport :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Shreveport : J. Gary Booker, Md, Apmc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Shreveport :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Maryland
Gaithersburg : Potomac Grove Clinical Research Center
An Investigational Medication for Major Depressive Disorder
Gaithersburg : Potomac Grove Clinical Research Center
Major Depressive Disorder and Sexual Dysfunction
View More »
Baltimore : Pharmasite Research Inc
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Baltimore : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Baltimore : Pharmasite Research Inc
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Baltimore : Pharmasite Research, Inc. Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Baltimore :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Baltimore :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Baltimore : Johns Hopkins Community Phsyicians
Patient-Centered Depression Care for African Americans
Baltimore : Johns Hopkins School of Medicine
Patient-Centered Depression Care for African Americans
Baltimore : Sinai Hospital
Patient-Centered Depression Care for African Americans
Baltimore : Baltimore Medical Systems, Middlesex Health Center
Patient-Centered Depression Care for African Americans
Baltimore : Call for Information (Investigational Site 0033)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
Baltimore : Johns Hopkins University
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Baltimore : Sheppard Pratt Health System Updated
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Gaithersburg :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Gaithersburg : Potomac Grove Clinical Research Center Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Rockville : Neuroscientific Insights
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Rockville :
A Study of Ketamine in Patients With Treatment-resistant Depression
Rockville : Office of Marc Hertzman, MD Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Massachusetts
Haverhill : ActivMed Practices & Research, Inc.
Are you between the ages of 18 and 65 and suffering from Depression?
Roslindale : Boston Clinical Trials Updated
Are you still Depressed?
Roslindale : Boston Clinical Trials Updated
Do you often feel sad, down and unmotivated?
Have you been taking medication for depression but still have symptoms?
Roslindale : Boston Clinical Trials Updated
I Feel Blue…
Roslindale : Boston Clinical Trials Updated
Stuck with Depression? You are not alone.
View More »
Belmont : McLean Hospital - McLean Imaging Center
Functional and Neurochemical Correlates of Treatment Response in Major Depressive Disorder
Belmont : McLean Hospital
Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder (MDD) Partly Responsive to Selective Serotonin Reuptake Inhibitor (SSRI) or Selective Norepinephrine Reuptake Inhibitor (SNRI) Treatment
Belmont : Mclean Hospital
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Boston : Boston Clinical Trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Boston :
A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Boston :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Boston : Massachusetts General Hospital
Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability
Boston : Massachusetts General Hospital - Center for Anxiety and Traumatic Stress Disorders
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
Boston : Massachusetts General Hospital - Center for Anxiety and Traumatic Stress Disorders
Major Depressive Disorder With Mixed Features - Extension
Boston : Massachusetts General Hospital- Depression Clinical and Research Program
Transcranial Laser Therapy for Major Depressive Disorder
Cambridge : Cambridge Health Alliance
Ropinirole in the Treatment of Bipolar Depression
Chelsea : Chelsea Counseling Center- North Suffolk Mental Health Association
Transcranial Laser Therapy for Major Depressive Disorder
Watertown : Adams Clinical Trials, LLC Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Watertown : Teva Investigational Site 603
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Weymouth :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Woburn : Woburn Pediatric Associates
Study of Technology-assisted Treatment of Adolescent Depression
Michigan
Ann Arbor : Michigan Head Pain and Neurological Institute
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Mississippi
Flowood : Precise Research Centers
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Flowood : Precise Research Centers
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Flowood :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Flowood :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Flowood :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Missouri
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Are you down in the dumps with your diabetes?
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Depression Research Study Seeks Volunteers with Heart Failure.
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Pre-diabetes: Are you at risk?
View More »
Creve Coeur : Millennium Psychiatric Associates, LLC
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Creve Coeur : Millennium Psychiatric Associates, LLC
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Creve Coeur : Millennium Psychiatric Associate
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Creve Coeur :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Gladstone : Comprehensive Psychiatric Associates
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Kansas City : The Center for Pharmaceutical Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
O'Fallon : Psyichatric Care and Research Center
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
St. Charles : Midwest Research Group
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
St. Charles : Midwest Chest Consultants
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
St. Charles : St. Charles Psychiatric Associates - Midwest Research Group
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
St. Charles : St. Charles Psychiatric Associates - Midwest Research Group Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
St. Charles : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
St. Louis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
St. Louis : Scientella LLC
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
St. Louis :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
St. Louis :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
St. Louis : Mercy Health Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
St. Louis :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
St. Louis : St. Louis Clinical Trials
Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
St. Louis : Mid-America Clinical Research, LLC
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
St. Louis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
St. Louis : Washington University School of Medicine Updated
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Nebraska
Lincoln : Premier Psychiatric Research Institute, LLC
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Lincoln : Premier Psychiatric Research Institute, LLC
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Lincoln : Premier Psychiatric Group
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Lincoln : Premier Psychiatric Research Institute, LLC.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
North Platte : Heartland Pharma Development
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
View More »
North Platte :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Omaha : Quality Clinical Research, Inc.
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Omaha : Creighton University, Department of Psychiatry
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Omaha : University of Nebraska Medical Center Updated
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Nevada
Las Vegas : Center for Psychiatry and Behavioral Medicine, Incorporated
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Las Vegas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Las Vegas : Center for Psychiatry and Behavioral Medicine, Incorporated
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Las Vegas :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Las Vegas : Clinical Research Consortium
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
New Hampshire
Keene : Family Medicine Clinics, Cheshire Medical Center (DH-Keene)
Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E Trial
Nashua : Greater Nashua Mental Health Center
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
New Jersey
Cherry Hill : Center For Emotional Fitness Updated
DEPRESSION
Cherry Hill : University of Medicine and Dentistry of New Jersey - School of Osteopathic Medicine
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Mount Laurel : CRI Lifetree Updated
Do you or a loved one suffer from Depression?
New Brunswick : UMDNJ-Robert Wood Johnson Medical School
Coping With Depression in Parkinson's Disease
View More »
Berlin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Cherry Hill :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Cherry Hill : Center for Emotional Fitness
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Cherry Hill : Center for Mood Disorders and Neuromodulation Therapies, UMDNJ-SOM Updated
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Marlton :
A Study of Ketamine in Patients With Treatment-resistant Depression
Marlton : CRI Lifetree
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Marlton :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Toms River :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Toms River : Bio Behavioral Health
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Toms River : Bio Behavioral Health
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Willingboro :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Willingboro : CRI Worldwide LLC
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
New Mexico
Albuquerque :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Albuquerque : Albuquerque Neuroscience, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Albuquerque : Albuquerque Neuroscience, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Albuquerque : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
New York
Bronx : Biomedical Research Alliance of New York
Major Depressive Disorder
New York : Clinilabs, Inc.
Are anti-depression medications just not working for you? (New York, NY)
New York : Medical & Behavioral Health Research, PC
Bipolar Depression
New York : Medical & Behavioral Health Research, PC
Bipolar Depression Research Study
New York : Medical & Behavioral Health Research, PC
Depressed?
New York : Medical & Behavioral Health Research, PC
DEPRESSED? 18-65 YEARS OLD?
New York : Clinilabs, Inc.
Feeling Depressed?
New York : Clinilabs, Inc.
Have you been diagnosed with major depression? Do you continue to have symptoms despite medications?
New York : Clinilabs, Inc.
Have you been diagnosed with major depression? Do you continue to have symptoms despite medications?
New York : Biomedical Research Alliance of New York
Major Depressive Disorder
View More »
Bronx : James J. Peters VAMC
Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-Treated Chronic Pain Patients: A Pilot Study.
Bronx : Montefiore Medical Center
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Brooklyn : Social Psychiatry Research Institute
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Brooklyn : Brooklyn Medical Institute
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Brooklyn : Social Psychiatry Research Institute
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Brooklyn :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Brooklyn : Teva Investigational Site 207
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Buffalo :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Cedarhurst :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Cedarhurst : Neurobehavioral Research, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Cedarhurst :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Fresh Meadows : Comprehensive Clinical Development, Inc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Glen Oaks : The Zucker Hillside Hospital
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Jamaica : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Mount Kisco : Bioscience Research, LLC.
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Mount Kisco : Bioscience Research, LLC.
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Mount Kisco : Bioscience Research, LLC Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Mount Kisco : Bioscience Research, Llc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
New York :
A Study of Ketamine in Patients With Treatment-resistant Depression
New York :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
New York : New York State Psychiatric Institute/Columbus Circle Midtown
Desvenlafaxine vs. Placebo Treatment of Chronic Depression
New York : Depression Evaluation Service (DES), New York State Psychiatric Institute, Columbia University Department of Psychiatry
Desvenlafaxine vs. Placebo Treatment of Chronic Depression
New York :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
New York : Fieve Clinical Research Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
New York : Medical & Behavioral Health Research, PC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
New York :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
New York : Village Clinical Research, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
New York : New York State Psychiatric Institute
NMDA Antagonists in Bipolar Depression
New York : New York State Psychiatric Institute, 1051 Riverside Drive
Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression
New York : Call for Information (Investigational Site 0039)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
New York : Spectrum Neuroscience
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
New York : Mount Sinai Hospital
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
New York : Columbia University / New York State Psychiatric Institute
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
New York : Mount Sinai School of Medicine
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
New York : Clinlabs, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
New York : Teva Investigational Site 202
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
New York : Mount Sinai School of Medicine Updated
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Rochester : Finger Lakes Clinical Research
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Rochester : Finger Lakes Clinical Research
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Rochester :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Rochester : Finger Lakes Clinical Research
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Staten Island :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Staten Island : Richmond Behavioral Associates Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Staten Island :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Staten Island : Call for Information (Investigational Site 0411)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
Staten Island : Teva Investigational Site 411
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Staten Island : Teva Investigational Site 110
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Stony Brook : Stony Brook University Medical Center
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Stony Brook : Stony Brook University Medical Center
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
West Seneca : Private Practice - Daniel I. Rifkin MD PC
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
White Plains : Weill Cornell Medical College
International Study to Predict Optimised Treatment - in Depression
North Carolina
Charlotte : Carolinas Healthcare System
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Durham : Triangle Neuropsychiatry Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Durham : Psychiatry and Behavioral Sciences, Duke
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
Durham : Psychiatry and Behavioral Sciences, Duke
Major Depressive Disorder With Mixed Features - Extension
Durham : Duke Medical Center Department of Psychiatry & Behavioral Sciences
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
View More »
Durham : Duke University Brain Stimulation and Neurophysiology Center Updated
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Hickory : Clinical Trials of America, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Hope Mills : Inquest Clinical Group/ Global Research Associates
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Raleigh :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Raleigh : Rcihard H. Weisler, MD, PA & Associates Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Raleigh : Richard H. Weisler, Md, Pa & Assoc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Raleigh : Call for Information (Investigational Site 0052)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
Ohio
Cincinnati : Community Research
Feeling Depressed?
Cincinnati : Community Research
Not seeing the results you want from your antidepressant?
View More »
Avon lake :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Beachwood :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Beachwood :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Beachwood : Northcoast Clinical Trials, Inc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Beachwood : Call for Information (Investigational Site 0414)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
Beachwood : North Coast Clinical Trials, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Canton : Neuro-Behvioral Clinical Research, Inc.
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Canton : Neuro-Behavioral Clinical Research, Inc
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Canton :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Cincinnati : University of Cincinnati
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Cincinnati : Cincinnati Children's Hospital Medical Center
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Cincinnati :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Cincinnati :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Cincinnati : Community Research Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Cincinnati : Patient Priority Clinical Sites, Llc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Cincinnati : US002
Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder
Cincinnati : Teva Investigational Site 610
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Cleveland : Discovery and Wellness Center for Children/University Hospitals Case Medical Center
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Cleveland : Discovery and Wellness Center for Children/University Hospitals Case Medical Center
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Cleveland : University Hospitals Case Medical Center
Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance
Columbus : Radiant Research, Inc.
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Columbus : Ohio State University, Dept. of Psychiatry
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Dayton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Dayton : Midwest Clinical Research Center
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Dayton :
A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Dayton : Midwest Clinical Research Center
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Dayton :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Dayton :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Dayton : Midwest Clinical Research Center
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Dayton : Midwest Clinical Research Center
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Garfield Heights :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Mason : Lindner Center of HOPE
Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression
Mason : Lindner Center of HOPE Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Mason : Lindner Center of HOP
Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression
Middleburg Heights : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Middleburg Heights : North Star Medical Research, LLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Toledo :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Toledo :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Toledo : Neurology & Neuroscience Center Of Ohio
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Toledo : Teva Investigational Site 615
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Oklahoma
Enid : Cutting Edge Research of Enid
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Oklahoma City : IPS Research Company
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Oklahoma City : Cutting Edge Research Group
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Oklahoma City : IPS Research Company
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Oklahoma City : Cutting Edge Research of Enid
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
View More »
Oklahoma City : Oklahoma Clinical Research Center
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Oklahoma City :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Oklahoma City :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Oklahoma City : SP Research, PLLC Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Oklahoma City : Sooner Clinical Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Oklahoma City :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Oklahoma City : Ips Research Company
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Oklahoma City :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Oklahoma City : IPS Research Company
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Oklahoma City : Teva Investigational Site 609
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Oklahoma City : Teva Investigational Site 401
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Tulsa : Tulsa Clinical Research, Llc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Oregon
Portland : Summit Research Network (Oregon), Inc.
Depression Research Study
View More »
Medford : Sunstone Medical Research, LLC
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Portland : Summit Research Network (Oregon), Incorporated
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Portland : Summit Research Network (Oregon), Incorporated
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Portland :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Portland :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Portland : Summit Research Network (Oregon) Inc. Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Portland : Summit Research Network (Oregon) Inc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Portland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Salem : Oregon Center For Clinical Investigations, Inc (Occi, Inc)
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Pennsylvania
Media : Suburban Research Associates
Are you suffering from depression symptoms?
View More »
Allentown : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Allentown :
A Study of Ketamine in Patients With Treatment-resistant Depression
Allentown : Lehigh Center for Clinical Research
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Allentown :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Allentown :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Allentown : Lehigh Center for Clinical Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Allentown :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Allentown : Teva Investigational Site 406
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Chalfont : Genomind, LLC
An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay
Media :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Media :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Media : Suburban Research Associates Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Media : Suburban Research Associates
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Norristown :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Norristown : Keystone Clinical Studies, Llc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Philadelphia :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Philadelphia : CRI Worldwide LLC Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Philadelphia : Belmont Center for Comprehensive Treatment
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Philadelphia :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Philadelphia : Thomas Jefferson University
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Philadelphia : University Of Pennsylvania
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Philadelphia :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Philadelphia : CRI Lifetree- Philadelphia Research Center
Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
Philadelphia : Thomas Jefferson University
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Philadelphia : University of Pennsylvania Updated
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Pittsburgh : University of Pittsburgh Medical Center (UPMC)
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Pittsburgh : University of Pittsburgh School of Medicine Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Pittsburgh :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Pittsburgh : Mood Disorders Treatment Research Program University of Pittsburgh-Western Psychiatric Institute and Clinic Updated
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
West Chester : University Services
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Wyomissing : Clinical Research Center of Reading, LLP
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Wyomissing : Behavioral Medicine Center
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Rhode Island
Lincoln : Lincoln Research - Rhode Island
Announcing a medical research study for adults with DEPRESSION and FATIGUE?
Lincoln : Lincoln Research - Rhode Island
Depressed...? Approximately one in 10 people suffer from depression...you are not alone.
Lincoln : Lincoln Research - Rhode Island
Do you feel Depressed? Announcing a medical research study for people with depression.
Lincoln : Lincoln Research - Rhode Island
Is the burden of Depression weighing you down...despite medication?
Lincoln : Lincoln Research - Rhode Island
Suffering from bipolar depression and are depressed and on medication?
View More »
East Greenwich : Costal Medical
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
East Providence : Rhode Island Mood & Memory Research Institute Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Lincoln :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Lincoln : Lincoln Research
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Providence : Butler Hospital Mood Disorders Research Program, Brown Department of Psychiatry and Human Behavior Updated
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Warwick : Omega Medical Research
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
South Carolina
Greer : Radiant Research - Greer
Clinical Research Study for Depression
Mt. Pleasant : Coastal Carolina Research Center
Volunteers who suffer from Fibromyalgia pain and also Depression are needed for a new clinical research study.
View More »
Charleston :
A Study of Ketamine in Patients With Treatment-resistant Depression
Charleston :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Charleston : Medical Uni. Of South Carolina (MUSC)
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Charleston : MUSC Institute of Psychiatry, Brain Stimulation Lab Updated
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Columbia :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Columbia :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Columbia : Carolina Clinical Research Services
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Mt. Pleasant : Coastal Carolina Research Center
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
North Charleston : Medical University South Carolina Anxiety Disorder Program
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Tennessee
Nashville : Clinical Research Associates
Major Depression
View More »
Franklin : Psychiatric Consultants, PC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Franklin :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Franklin : Psychiatric Consultants, Pc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Memphis : Research Strategies of Memphis, LLC
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Memphis : Clinical Neuroscience Solutions, Incorporated
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Memphis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Memphis : Research Strategies of Memphis, LLC
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Memphis : Clinical Neuroscience Solutions, Incorporated
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Memphis :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Memphis : Research Strategies of Memphis, LLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Memphis : Clinical Neuroscience Solutions, Inc. Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Memphis :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Memphis : Clinical Neuroscience Solutions, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Memphis :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Nashville : Clinical Research Associates Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Nashville : Centerstone
Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1)
Texas
Austin : FutureSearch Trials - Austin Updated
Are You Taking Antidepressants and Experiencing Sexual Side Effects?
Dallas : Research Across America
Major Depression
Houston : Bayou City Research Corporation
Still Depressed?
San Antonio : Croft Group Research Center
Are you DEPRESSED?
San Antonio : Croft Group Research Center
Are you taking an antidepressant but still depressed?
San Antonio : Croft Group Research Center
Have you had several depressive episodes?
San Antonio : Radiant Research - San Antonio
Research Study for Depression
View More »
Austin : FutureSearch Clinical Trials, L.P.
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Austin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Austin : FutureSearch Trials of Neurology
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Austin : FutureSearch Clinical Trials, L.P.
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Austin :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Austin : FutureSearch Clinical Trials, LP Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Austin : Community Clinical Research, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Austin : Senior Adults Specialty Research
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Dallas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Dallas :
A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Dallas :
A Study of Ketamine in Patients With Treatment-resistant Depression
Dallas : University of Texas Southwestern Medical Center
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Dallas :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Dallas :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Dallas : KRK Medical Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Dallas : Future Search Trials of Dallas, LP
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Dallas :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Dallas : Futuresearch Trials Of Dallas
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Dallas : Dept. of Psychiatry, UT Southwestern Medical Center
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
Dallas : Dept. of Psychiatry, UT Southwestern Medical Center
Major Depressive Disorder With Mixed Features - Extension
Dallas : UT Southwestern Medical Center at Dallas
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Dallas : Pillar Clinical Research, LLC
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Dallas : UT Southwestern Medical Center Updated
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Desoto : Insite Clinical Research
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Desoto : Teva Investigational Site 403
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Friendswood : Bay Area Clinical Services
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Friendswood : Teva Investigational Site 612
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Houston : Claghorn-Lesem Research Clinic
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Houston : Clinical Trial Network
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Houston :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Houston :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Houston : Ben Taub General Hospital
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Houston : Ut Health-Houston
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Houston : Red Oak Psychiatry Associates, Pa
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Houston : Call for Information (Investigational Site 0031)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
Houston : Houston Clinical Trials, LLC
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
San Antonio : Univ of Texas Helath Science Center at San Antonio
12- Week Open Label Treatment of Refractory Bipolar Depression
San Antonio : Clinical Trials of Texas
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
San Antonio : Clinical Trials of Texas, Inc.
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
San Antonio : Clinical Trials of Texas, Inc.
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
San Antonio : Clinical Trials of Texas, Inc
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
San Antonio : Clinical Trials of Texas, Inc.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
The Woodlands :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Wharton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Wharton : Wharton Research Center, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Wichita Falls : Grayline Clinical Drug Trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Wichita Falls : Grayline Clinical Drug Trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Wichita Falls : Grayline Clinical Drug Trials
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Wichita Falls : Grayline Clinical Drug Trials
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Utah
Murray : Radiant Research - Salt Lake City
Clinical Research Study for Depression
Murray : Radiant Research - Salt Lake City
Depression Research Study
Murray : Radiant Research - Salt Lake City
Research Study for Depressiondep
Salt lake City : Lifetree Clinical Research Updated
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Salt Lake CIty : Lifetree Clinical Research
Depression
Salt Lake CIty : Lifetree Clinical Research
Depression
Salt Lake CIty : Lifetree Clinical Research
Depression
Salt lake City : Lifetree Clinical Research Updated
Major Depressive Disorder With Ongoing Inadequate Response to An Antidepressant
Salt lake City : Lifetree Clinical Research Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Salt Lake City : CRI Lifetree
This study is designed to evaluate the efficacy, safety, and tolerability of cariprazine
relative to placebo for the treatment of major depressive disorder as an adjunct to ADT
Salt Lake City : CRI Lifetree
To compare the change from baseline (Week 7 in Phase B) to endpoint (Week 13 in Phase C) in MADRS score of 2 fixed-doses of BMS-820836 (1 and 2 mg/day) versus continuation of the antidepressant treatment to which inadequate response has been prospectively demonstrated in subjects with TRD.
Salt Lake City : CRI Lifetree
To evaluate the efficacy of 6 weeks treatment of RO4995819 versus placebo as adjunctive therapy in patients with MDD having inadequate response to ongoing antidepressant treatment based on mean change in Montgomery Asberg Depression Rating Scale (MADRS) scores from baseline to end of treatment.
Salt Lake City : CRI Lifetree
To evaluate the efficacy of 6 weeks treatment of RO4995819 versus placebo as adjunctive therapy in patients with MDD having inadequate response to ongoing antidepressant treatment based on mean change in Montgomery Asberg Depression Rating Scale (MADRS) scores from baseline to end of treatment.
Salt Lake City : CRI Lifetree
To evaluate the efficacy of treatment with flexible doses of Lu AA21004 (10 or 20 mg QD) versus placebo on cognitive dysfunction in patients with MDD
Salt Lake City : CRI Lifetree
To evaluate the mean difference in Hamilton Depression Rating Scale 17 (HDRS-17) score for the combined GLYX 13 group mean change versus the placebo group mean change at the end of a 6 week randomized withdrawal phase (predose baseline score - score at end of randomized withdrawal period).
View More »
Clinton : Ericksen Research and Development Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Clinton : Ericksen Research And Development
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Clinton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Murray : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Murray :
A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Murray : Radiant Research, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Murray : Call for Information (Investigational Site 0406)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
Orem :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Salt Lake City : Lifetree Clinical Research, LC
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Salt Lake City : Fatigue Consultation Clinic
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Salt Lake City :
A Study of Ketamine in Patients With Treatment-resistant Depression
Salt Lake City : Lifetree Clinical Research
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Salt Lake City :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Salt Lake City : University of Utah
Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram
Salt Lake City :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Salt Lake City : Clinical Methods Llc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Salt Lake City : Psychiatric And Behavioral Solutions
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Vermont
Woodstock : Neuropsychiatric Associates
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Virginia
Charlottesville : Charlottesville Medical Research
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Charlottesville :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Richmond : Virginia Commonwealth University
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Richmond : Virginia Treatment Center for Children
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Richmond : Alliance Research Group
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
View More »
Richmond : Virginia Commonwealth University
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Richmond : Virginia Treatment Center for Children
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Richmond : Alliance Research Group
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Richmond :
A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Richmond : Alliance Research Group
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Roanoke :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Washington
Seattle : Summit Research Network (Seattle) LLC
Depression Research Study
View More »
Bellevue : Northwest Clinical Research Center
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Kirkland : Eastside Therapeutic Resource
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Kirkland : Eastside Therapeutic Resource
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Kirkland :
A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Kirkland :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Kirkland : Call for Information (Investigational Site 0415)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
Kirkland : Teva Investigational Site 613
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Richland : Scientella, LLC.
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Seattle : Summit Research Network (Seattle) LLC
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Seattle : Summit Research Network (Seattle) LLC
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Seattle :
A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Seattle :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Seattle :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Seattle : Summit Research Network (Seattle) LLC Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Seattle :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Seattle : Summit Research Network (Seattle) Llc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Spokane : Teva Investigational Site 605
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Wisconsin
Brown Deer :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Brown Deer : Northbrooke Research Center
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Middleton : Dean Foundation For Health Research & Education
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Middleton : Dean Foundation for Health, Research and Education, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Milwaukee : Rogers Center for Research and Training, Incorporated
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
View More »
Milwaukee : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Milwaukee : Rogers Center for Research and Training, Incorporated
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Milwaukee :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Waukesha :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Waukesha : Independent Psychiatric Consultants, Sc, Dba, Ipc Research
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Waukesha : Independent Psychiatric Consultants, SC, dba, IPC Research
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Argentina
Buenos Aires : Cervino
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Buenos Aires : Instituto Nacional de Psicopatologia
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Buenos Aires : Teva Investigational Site 134
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Buenos Aires : Teva Investigational Site 136
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Caba : Centro Medico de Medicina Familiar Mind Out Research
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
View More »
Caba : BA Psychiatric Research Center
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Cordoba : Instituto Medico SAMIC
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Australia
Adelaide : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Brisbane : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Heidelberg : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Melbourne : Monash Alfred Psychiatry Research Centre
Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression
Nedlands : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
View More »
Sydney : The University of New South Wales/ Black Dog Institute
A Study of Omega-3 as a Treatment for Major Depression
Sydney : The University of New South Wales/Black Dog Institute
A Study of Omega-3 as an Augmentor of Antidepressant Treatment for Major Depression
Austria
Innsbruck :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Wien :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Wien : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Belgium
Duffel :
Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder Patients
Leuven :
Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder Patients
Sint Niklaas : Dr Lieven De Weirdt
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Brazil
Rio de Janeiro : Teva Investigational Site 624
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Bulgaria
Bourgas :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Kazanlak :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Kazanlak :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Kazanlak : Teva Investigational Site 148
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Novi Iskar :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
View More »
Pazardjik : Teva Investigational Site 853
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Pleven : Teva Investigational Site 852
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Rousse :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Ruse : Teva Investigational Site 370
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Sofia :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Sofia :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Sofia : Teva Investigational Site 247
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Sofia : Teva Investigational Site 855
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Sofia : Teva Investigational Site 854
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Tzerova Koria :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Varna :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Varna : Teva Investigational Site 851
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Varna : Teva Investigational Site 856
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Canada
Brampton : Aggarwal & Associates Ltd. Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Burlington :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Burlington : Depression, Mood Disorders and Schizophrenia Treatment Centre Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Chatham : Chatham-Kent Clinical Trials Research Center Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Gatineau : Pierre-Janet Hospital Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
View More »
Hamilton : Women's Health Concerns Clinic
Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and Women
Hamilton : Women's Health Concerns Clinic
Duloxetine for Major Depression in Peri-/Postmenopausal Women
Hamilton : Centre for Anxiety, Attention Deficit and Trauma
Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity
Hamilton : St. Joseph's Healthcare, Centre for Mountain Health Services
Longitudinal Study of People Presenting for First Treatment of a Mood Disorder
Hamilton : MacAnxiety Research Centre
Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders
Kelowna :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Kingston :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Kingston :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Kirkland : Merck Frosst Canada
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
London : Regional Mental Health Care
Aripiprazole and Resistant Postpartum Depression
London : Regional Mental Health Care Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Medicine Hat :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Mississauga :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Mississauga : Anxiety and Mood Disorder Center Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Mississauga : Medical Research Associates Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Montreal : Centre de Recherche Fernand-Seguin
Effect of Antidepressants on White Matter Structure
Montreal : l'Hopital Louis H. Lafontaine Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Montreal : Centre de Recherche Fernand Seguin
Inflammatory Markers and Cognitive Function in Major Depression
Montreal : Immunodeficiency Service Montreal Chest Institute McGill University Health Centre
Trial of Citalopram for the Prevention of Depression
Montréal : Douglas Mental Health University Institute
Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study
Oakville : A.K. Karan Holdings Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Ottowa :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Parry Sound : International Sleep Clinic, West Parry Sound Health Centre Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Penticton : Dr. Alexander McIntyre Inc.
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Penticton :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Penticton : Dr. Alexander McIntyre Inc Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Pointe-Claire : Kells Medical Research Group Inc. Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Quebec : ALPHA Recherche Clinique Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Sherbrooke : Diex Research Sherbrooke Inc.
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Sherbrooke :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Sherbrooke : Q&T Research Sherbrooke Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Sydney :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Thornhill : Canadian Centre for Clinical Trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Toronto : Toronto General Hospital
A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression
Toronto : START Clinic for Mood and Anxiety Disorders Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Toronto : Sleep & Alertness Clinic (Sleep & Alertness Research, Inc.) Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Toronto : Manna Research Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Toronto : Univ Health Network, Toronto Western Hospital Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Toronto : Center for Addiction and Mental Health (CAMH)
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Vancouver : University of British Columbia
Are Antidepressants More Effective Than Placebo, When Given in Combination With Mood Stabilizers, in Preventing Mood Episodes in People With Bipolar I Disorder?
Vancouver : Solid Organ Transplant Clinic, Vancouver General Hospital
Comparison of Medication Adherence Between Once and Twice Daily Tacrolimus in Stable Renal Transplant Recipients
Vancouver : University of British Columbia, Department of Psychiatry
Neurocognition and Work Productivity in Major Depressive Disorder (MDD)
Vancouver : Institute of Mental Health, University of British Columbia
What is the Antidepressant Mechanism of Action of Quetiapine in Bipolar Depression?
Verdun :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Windsor : Windsor Regional Hospital-Tayfour Campus Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Chile
Antofagasta : Psocomed Estudios Medicos
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Las Condes : Especialidades Medicas L y S
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Las Condes : Centro de Estudios y Tratemiento de Enfermedades Psiquiatricas
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Providencia : Biomedica Research Group
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Providencia : Centro de Estudios Clinicos
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
View More »
San Bernardo : Unidad de Salud Mental y Psiquietriea Hospital y CRS El Pino
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
San Miguel : Hospital Barros Luco Trudsau
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Santiago :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
China
Baoding : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
Baoding : CN005
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Beijing : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
Beijing : CN001
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Beijing : CN004
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
View More »
Beijing : CN006
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Beijing : Institute of mental health, Peking University
The Third Survey of Prescription Pattern of Psychotropic Drugs in China
Changsha : The Second Xiangya Hospital of Central South University
A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression
Changsha : CN003
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Chengdu : CN013
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Guang Zhou : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
Guang Zhou : CN011
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Hangzhou : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
Kunming : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
Kunming : CN002
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Nanjing : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
Shanghai : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
Shanghai : CN012
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Taiyuan : CN014
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Tianjin : CN007
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Xi'An : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
Xi'an : CN008
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Xi'an : CN009
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Xi'an : CN015
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Croatia
Rijeka : Teva Investigational Site 635
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Split : Teva Investigational Site 631
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Zagreb : Psychiatric Clinic Vrapoe Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Zagreb : Poliklinika Neuron Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Zagreb : Teva Investigational Site 634
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
View More »
Zagreb : Teva Investigational Site 633
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Czech Republic
Brno : Saint Anne s.r.o.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Brno : Psychiatricka ambulance
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Horovice : Medicana s.r.o.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Kutna Hora : Psychiatrie s.r.o.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Litomerice : Bialbi s.r.o.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
View More »
Prague 10 : Clintrial s.r.o.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Prague 5 : Psychiatry Trial s.r.o.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Prague 6 : Prague Medical Services s.r.o.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Ricany : Ricany s.r.o.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Denmark
Roskilde : The day clinic for treatment of non-psychotic disorders (Roskilde Psychiatry)
Mindfulness-based Behavioural Therapy (MIBT) Versus Psychodynamic Therapy for Patients With Major Depressive Disorder in Psychotherapeutic Day Treatment. A Randomised Clinical Pilot Trial
Estonia
Parnu : Parnu Hospital, Psychiatric Clinic
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Tallinn : North Estonia Medical Centre Foundation Psychiatry Clinic
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Tallinn : Marienthal Psychiatry and Psychology Center
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Tartu : Jaanson & Laane OU
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Tartu : Tartu University Hospital Psychiatric Clinic
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Finland
Espoo : MSD Finland Oy
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
Helsinki : ARTES Psykiatrinen Palvelukeskus Oy
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Helsinki :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Helsinki : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Jarvenpaa : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
View More »
Kuopio : FI001
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Kuopio : Satucon Oy
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Kuopio :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Oulu : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Tampere : Satakunnan Psykiatripalveiu Oy at Mentoria Oy
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Tampere : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Turku : Puutorin Psykiatripalvelu
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Turku :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
France
Besancon : CHU Besancon - Clinical Psychaitric Department
Study of Transcranial Direct Current Stimulation (tDCS) as add-on Treatment for Resistant Major Depression
Besançon : C.H.U. Saint-Jacques - Service de Psychiatrie de l'Adulte
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Bron : C.H. Le Vinatier - EA 4166, UCB Lyon 1 - Department of Psychiatry - Service du Pr d'AMATO
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Clermont Ferrand : C.H.U. Gabriel Montpied - Service de Psychiatrie et Psychologie Médicale - CMP A
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Colombes : Hôpital Louis Mourier
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
View More »
DAX : Research Site
Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder
Dijon : C.H.U. Dijon, Hôpital Général - Service de Psychiatrie et d'Addictologie
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Dole : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Douai : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Elancourt : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Grenoble : C.H.U. de Grenoble, Hôpital sud - Département de Psychiatrie
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Jonzac : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Lézignan-Corbières : ASM Limoux
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Lille : Hôpital Fontan - C.H.R.U. Lille
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Limoges Cedex : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Marseille : C.H. Sainte Marguerite
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Montpellier : CHU
Pulmonary Hypertension, Quality of Life and Psychosocial Factors
Montpellier : CHU - Hôpital La Colombière
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Montpellier Cedex 5 : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Nice : Hôpital Pasteur - CHU Nice
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Paris : FR
A Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder
Paris : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Paris : Hôpital Sainte Anne - Service Hospitalo-Universitaire de Santé Mentale et de Thérapeutique
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Paris : MSD France
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
Poitiers : C.H.U. de POITIERS
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Rennes : C.H.U. - C.H. Guillaume Régnier
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Rouen : C.H.U. Charles Nicolle - Service Hospitalo-Universitaire de Psychiatrie
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Saint-Denis : EPS de Ville Evrard - Unité de Saint-Denis
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
St Etienne cedex : CHU St Etienne - Hôpital Nord
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Tours : CPU CHRU de Tours
BDNF Gene Polymorphism and Antidepressants Treatment
Germany
Achim : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Achim : Gemeinschafstpraxis für Neurologie und Psychiatrie, Psychotherapie
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Achim : Teva Investigational Site 655
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Altenholz-Stift : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Aschaffenburg : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
View More »
Augsburg : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Bad Honnef : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Bad Saarow : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Baesweiler : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Bayreuth : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Berlin : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Berlin : Private Praxis Dr. Jana Thomsen
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Berlin : emovis GmbH
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Berlin : Alexander Schulze, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Berlin :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Berlin :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Berlin : DE002
Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder
Berlin : Center for Epidemiology and Health Research
Visanne Post-approval Observational Study (VIPOS)
Bielefeld : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Bochum : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Bochum : Private Practice Drs. Bitter/Schumann
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Bochum :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Bonn : University Clinic Bonn
The Effect of Duloxetine on Interoceptive Awareness
Bremerhaven : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Buchholz : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Butzbach : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Chemnitz :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Cologne : Teva Investigational Site 653
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Dortmund : Research Site
European Drug Utilization Study
Dresden : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Dresden : University Hospital Carl Gustav Carus
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Dresden : Teva Investigational Site 651
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Erfurt : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Essen : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Freiburg :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Grevenbroich : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Haar : Merck Sharp & Dohme GmbH
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
Hamburg : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Hannover : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Hannover :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Hannover :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Heidenheim : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Kastellaun : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Klingenmünster : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Königsbrück : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Leipzig : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Leipzig : ZSL Zentrum fuer medizinische Studien in Leipzig
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Lohr am Main : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Mainz :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Mainz : DE001
Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder
Mannheim : Central Institute of Mental Health
Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)
Mannheim :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Mannheim : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Marburg : Department of Clinical Psychology and Psychotherapy, Philipps University Marburg
End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)
Merzig : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Mittweida : Teva Investigational Site 652
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Muenchen : Studienzentrum Muenchen
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
München : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Munich : Klinik für Psychiatrie und Psychotherapie, Ludwig-Maximilians-Universität
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Munich : Department of Psychiatry and Clin. Radiology, Ludwig-Maximilian-University
Somatosensory Processing in Depression
Münster : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Nienburg : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Nuernberg : Studienzentrum Klinikum Nuernberg
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Nümbrecht : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Oberhausen : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Oldenburg : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Ostfildern :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Ostfildern : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Potsdam : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Schönau am Königssee : Klinikum Berchtesgadener Land, Schön Kliniken
End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)
Schwalmstadt-Treysa : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Schwerin : Somni bene GmbH
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Schwerin :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Siegen : Private Practice: Eugen Schlegel
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Sinsheim : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Stadtroda : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Stuttgart : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Telgte : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Tübingen : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Weil am Rhein : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Wermsdorf : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Westerstede : Studiezentrum Nord-West
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Westerstede :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Wiesbaden :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Wiesbaden :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Wuerzburg : Medizinisches Studienzentrum Wuerzburg
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Zwickau : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Hungary
Baja N/A :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Budapest :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Budapest : Semmelweis Univ. Dept.of Psychiatry
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Budapest : Teva Investigational Site 661
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Budapest : Teva Investigational Site 664
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
View More »
Budapest : Teva Investigational Site 662
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Gyor : Teva Investigational Site 665
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Gyõr :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Kalocsa :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Nagyerkei : Debrecent Egyetem Orvos es Egeszsegtudomanyl Centrum Pszichiatrai
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Nagykallo : Santha Kalman Mentalis Egeszsegkozpont es Szakkorhaz
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Nagykallo : Teva Investigational Site 666
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Nyiregyhaza : Josa Andras Teaching Hospital
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Sziget : Pecsi Tudomanyegyeiem Pszichiatriai es Pszichoterapias Klinika
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Israel
Beer Yaacov : Beer Yaacov Mental Health Center
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Hod Hasharon : shalvataMHC
Double Blind Randomized Controlled, H1 Coil In Subjects With Bipolar Depression
Jerusalem : Hadasah Ein-Karem Medical Center
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Netanya : Lev Hasharon
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Ramat Gan : Sheba Medical Center
Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer’s Disease, Vascular Dementia, and Mixed Vascular and Alzheimer’s Dementia
View More »
Tel Hashomer : Sheba Medical Center, Department of psychiatry
Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder
Italy
Catania : Teva Investigational Site 688
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Firenze : Teva Investigational Site 689
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Genova : Teva Investigational Site 686
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Milano : Azienda Ospedaliera Luigi Sacco - Polo Universitario
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Pisa : Teva Investigational Site 687
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
View More »
Roma : Teva Investigational Site 692
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Japan
Adachi-ku : Suzuki Hospital
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Adachi-ku : Suzuki Hospital
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Aichi : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing
Amagasaki : Arai Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Amagasaki-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
View More »
Anan-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Annaka-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Ashiya : Terauchi-Takahashi Psychiatric Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Ashiya : Terauchi-Takahashi Psychiatric Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Chiba : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing
Chiba : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2216684 in Patients With Major Depression Disorder
Chiyoda-ku : Iidabashi Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Chubu :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Chugoku :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Chuo-ku :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Fujioka-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Fujisawa-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Fukaya-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Fukuoka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Fukuoka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing
Fukuoka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing
Fukuoka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2216684 in Patients With Major Depression Disorder
Fukuoka : Tenjin Mental Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Fukuoka : Stress Care Yoshimura Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Fukuoka : Kuranari Psychiatry Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Fukuoka : Tenjin Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Fukuoka : Imato Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Fukuoka : Medical Corporation Shinseikai Kaku Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Fukuoka : Sugahara Tenjin Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Fukuoka : Stress Care Yoshimura Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Fukuoka : Kuranari Psychiatry Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Fukuoka : Akasaka Kato Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Fukuoka : Ange Psychiatric Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Fukuoka : Hiro Mental Clinic Tenjinminami
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Fukuoka-city :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Fukuoka-city : Hatsuki Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Fukuoka-shi : Stress Care Yoshimura Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Fukushima : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Fukushima : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing
Fukushima : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing
Fukushima : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2216684 in Patients With Major Depression Disorder
Hachioji-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Hatsukaichi : Fujikawa Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Hatsukaichi : Fujikawa Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Hatsukaichi-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Hirakata : Kuginuki Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Hiroshima : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing
Hiroshima : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing
Hiroshima-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Hokkaido : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing
Hokkaido : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing
Hokkaido : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2216684 in Patients With Major Depression Disorder
Hokkaido :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Hokkaido :
Long-term Study of FK949E in Elderly Bipolar Disorder Patients
Hokkaido :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Hokkaidou :
Study to Evaluate the Effect and Safety of FK949E in Major Depressive Disorder Patients
Hyogo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Hyogo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing
Hyogo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing
Hyogo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2216684 in Patients With Major Depression Disorder
Ibaraki :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Inzai : Nippon Medical School Chiba Hokusoh Hospital
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Inzai : Nippon Medical School Chiba Hokusoh Hospital
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Inzai-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Kanagawa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Kanagawa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing
Kanagawa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing
Kanagawa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2216684 in Patients With Major Depression Disorder
Kanagawa :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Kanazawa : National Hospital Organization Kanazawa Medical Center
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Kanazawa : National Hospital Organization Kanazawa Medical Center
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Kansai :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Kanto :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Kantou :
Study to Evaluate the Effect and Safety of FK949E in Major Depressive Disorder Patients
Katsushika-ku :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Katsushika-ku : Fuku Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Kawasaki : Medical Corporation Seishinkai Kishiro Mental Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Kawasaki : Medical Corporation Seishinkai Kishiro Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Kawasaki-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Kinki :
Study to Evaluate the Effect and Safety of FK949E in Major Depressive Disorder Patients
Kita-Ku :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Kitakyushu-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Kobe : Ikeuchi Psycho Induced Internal Med.Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Kobe : Tatsuta Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Kobe-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Kumamoto-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Kumamoto-shi : Yuge Hospital
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Kurashiki-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Kurayoshi-shi :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Kure : Hayakawa Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Kyoto :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Kyoto : Sagaarashiyama-Tanaka Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Kyoto : Sagaarashiyama-Tanaka Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Kyoto-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Kyushu :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Minato-ku : SAKURAZAKA CLINIC SophyAnce
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Minato-ku : Akasaka Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Musashino-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Nagano : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Nagano : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing
Nagano : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2216684 in Patients With Major Depression Disorder
Nagoya : Narumi Himawari Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Nagoya : Mizuho Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Nakano-ku : Heartcare Ginga Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Nakano-Ku : Harikae mental clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Nanyo-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Nara : Kyo Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Noda City : Nakamoto Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Noda City : Nakamoto Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Noda-City :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Okayama : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing
Okayama : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing
Omuta : Shiranui Hospital
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Omuta : Shiranui Hospital
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Omuta-city : Oka Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Osaka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing
Osaka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing
Osaka :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Osaka : JIN clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Osakasayama-shi : Shibamoto Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Osakasayama-shi : Shibamoto Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Osaka-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Osaka-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Saga : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Saga : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2216684 in Patients With Major Depression Disorder
Sagamihara : Yutaka Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Sagamihara : Yutaka Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Sagamihara-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Saitama : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing
Saitama : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing
Saitama : Misato Ekimae Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Saitama-city :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Saitama-city : Sakai Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Sapporo : Maruyamapark Mentalclinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Sapporo-Shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Sapporo-Shi : Kawamura Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Setagaya-ku : Sangenjaya Nakamura Mental Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Setagaya-ku : Sangenjaya Nakamura Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Setagaya-ku : Komazawa Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Shibuyaku : Yoyoginomori Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Shibuya-ku : Maynds Tower Mental Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Shibuya-ku : Omotesando Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Shibuya-ku : Maynds Tower Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Shikoku :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Shinagawa-Ku : Himeno Tomomi Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Shinagawa-ku : Meguro sta.East Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Shinjuku-ku :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Shinjuku-ku : Tokyo Kosei Nenkin Hospital
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Shinjuku-ku : Tamaki Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Shinjuku-ku : Tokyo Women's Medical University Hospital
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Shinjuku-ku : Kagurazaka Stress Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Shinjuku-ku : Tokyo Kosei Nenkin Hospital
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Shinjuku-ku : Nishi-Shinjuku Concieria Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Takasaki-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Tochigi : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing
Tochigi : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing
Tokushisma-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Tokyo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Tokyo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing
Tokyo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing
Tokyo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2216684 in Patients With Major Depression Disorder
Tokyo :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Tokyo :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Tokyo : Omotesando Mental Clinic 9F Success Aoyama
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Tokyo : Eto Mental Clinic Meguro
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Toshima-ku : Himorogi Psychiatric Institute
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Toshima-ku : Himorogi Psychiatric Institute
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Touhoku :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Utsunomiya-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Yokohama-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Yokohama-Shi : Azamino Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Yokosuka city : Shioiri Mental Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Yokosuka city : Shioiri Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Korea, Republic of
Ansan : 03
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Ansan : Korea University Ansan Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Anyang : 19
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Anyang : Hallym Univesity Sacred Heart Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Bucheon : KR005
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
View More »
Busan : 26
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Busan : 08
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Busan : Dong-A University Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Chungbuk : 23
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Daegu : 05
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Daegu : 04
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Daegu : Dongsan Medical Center
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Daejeon : Chungnam National University Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Daejon : 16
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Goyang : 28
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Goyang : Dongguk University International Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Goyang-si : Dongguk University International Hospital
Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients
Guri : Hanyang University Guri Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Gwangju : 24
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Gwangju : 29
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Gwangju : Chosun University Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Gyeonggi-Do : 11
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Gyeonggi-do : Kwandong University College of Medicine Myongji Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Inchon : Inha University Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Jinju : 15
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Kangnam : Samsung Medical Center
Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning
Seoul : Seoul National University Hospital
Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder
Seoul : Seoul National University Hospital
Lexapro®'s Efficacy After Dose Escalation in Remission Study
Seoul : Seoul National University Hospital
Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients
Seoul : Seoul St. Mary's Hospital
Quality of Life and Depression in Dialysis Patients
Seoul : 13
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 09
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 17
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 07
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 10
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 27
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 02
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 06
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 01
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 14
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 20
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 22
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 12
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 21
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 18
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : KR003
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Seoul : KR002
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Seoul : KR007
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Seoul : KR006
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Seoul : KR001
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Seoul : Severance Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Seoul : Konkuk Univ. Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Seoul : KyungHee University Medical Center
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Seoul : Asan Medical Center
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Sungnam : KR004
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Yangsan : 25
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Latvia
Daugavpils : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Jelgava : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Liepaja : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Sigulda : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Strenci : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Mexico
Aguascalientes :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Leon :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Leon Guanajuato : Hospital Aranda de la Parra Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Monterrey : Centro Regiomontano de Investigacion S.C. (CRI) Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Monterrey :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
View More »
Nuevo Leon : Instituto de Infromacion e Investigación en Salud Mental (INFOSAME) Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
San Luis Potosi : Consultorio Especializado en Psiquiatria Infantil y Adolescentes Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Sinaloa : B & B Investigaciones Medicas S.C. Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Monaco
Monaco : Centre Hospitalier Princesse Grace
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Norway
Drammen : MSD Norge A/S
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
Lorenskog : Akershus University Hospital
Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin Therapy
Philippines
Las Pinas : Private Clinic
Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients
Manila : Private Clinic
Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients
Pasay City : Private Clinic
Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients
Poland
?Uromin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Belchatow :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Bialystok : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Bialystok : Prywatne Gabinety Lekarskie "Promedicus"
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Bialystok :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
View More »
Bialystok : Teva Investigational Site 259
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Bydgoszcz : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Bydgoszcz : NZOZ Centrum Kultury, Higieny i Zdrowia Psychicznego
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Chelmno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Chelmno : Zespol Opieki Zdrowotnej w Chelmnie
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Choroszcz :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Gdansk : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Gdansk : Centrum Badan Klinicznuch Pl-House sp. z.o.o.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Gdansk : Klinika Chorob Psychicznych i Zaburzen Nerwicowych
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Gdansk : Teva Investigational Site 257
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Gdynia :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Gdynia : Teva Investigational Site 258
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Gorlice : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Gorlice : Centrum Psychiatrii i Psychoterapli
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Katowice : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Kielce : NZOZ Syntonia, Poradnia Zdrowia Psychicznego
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Kielce :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Krakow : Teva Investigational Site 155
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Leszno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Lodz :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Lublin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Lublin : Osrodek Badafi Klinicznych Prof dr hab n med Meszek Szczepanski Prywatna Praktyka Lekarska
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Skorzewo : Teva Investigational Site 255
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Szczecin : Teva Investigational Site 861
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Torun :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Tuszyn : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Tuszyn :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Tuszyn : Teva Investigational Site 157
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Zuromin : Samodzielny Publiczny Zespol Zakladow Opieki Zdrowotnej w Zurominie
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Puerto Rico
Ponce : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
San Juan : INSPIRA Clinical Research Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
San Juan : Dharma Institute & Research Center Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Romania
Arad :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Arad : Spitatul Clinic Judetean de Urgenta Arad, Clinica de Psihiatrie
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Botosani : Stefi-Dent SRL
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Bucaresti : Spitalui Clinic de Psihiatrie "Prof. Dr. Alexandru Obregia" Sectia Clinica Psihiatrie I
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Bucuresti :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
View More »
Constanta :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Craiova :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Iasi :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Oradea : Crucea Alba
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Targouiste :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Targoviste : Lorentina 2201 SRL
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Targu Mures : Spitalul Clinic Judetean Mures
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Targu Mures :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Russian Federation
Ekaterinburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Ekaterinburg :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Lipetsk :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Moscow : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Moscow :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
View More »
Nizny Novgorod :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Rostov-On-Don : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Saratov :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
St Petersburg :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
St. Petersburg :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
St. Petersburg :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
St-Peterburg :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
St-Petersburg :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Serbia
Belgrade : Teva Investigational Site 177
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Nis : Teva Investigational Site 837
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Slovakia
Bratislava :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Bratislava : Teva Investigational Site 699
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Rimavska Sobota :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Rimavska Sobota : Teva Investigational Site 697
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Roznava : Teva Investigational Site 696
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
View More »
Trencin :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Trencin : Teva Investigational Site 698
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
South Africa
Bellville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Bellville : Cape Trial Centre
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Bellville : Flexivest Fourteen Research Centre
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Bellville, Cape Town :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Cape Town : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
View More »
Cape Town : Teva Investigational Site 707
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Cape Town : Teva Investigational Site 712
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Cape Town, Western Cape :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Centurion : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Centurion : Vista Clinic
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Centurion : Teva Investigational Site 708
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Centurion, Pretoria :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
George : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
George : George Medi Clinic Extension
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Johannesburg : Private Practice - Gerta Brink
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Johannesburg : Teva Investigational Site 710
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Nieu Muckleneuk, Pretoria :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Paarl : Teva Investigational Site 711
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Pretoria : Teva Investigational Site 706
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Somerset West : Somerset West Clinical Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
West Cape : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Spain
Barcelona : Hospital de l�Esperan
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Barcelona : Instituto Universitario USP Dexeus
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Barcelona : Hospital Cl�c de Barcelona
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Barcelona : Servicio de Reumatologia,Institut Ferran de Reumatologia-Clinica CIMA
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Barcelona : Hospital Universitari de Bellvitge, Servicio de Psiquiatria Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
View More »
Barcelona : Hospital de la Santa Creo l Sant Pau Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Guadalajara : Hospital General Universitario de Guadalajara
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Madrid : Hospital General Universitario Gregorio Mara
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Madrid : Hospital Fundacion de Alcorcon Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Madrid : Hospital Universitario de Henares Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Madrid : Hospital Universitario Infanta Leonor Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Oviedo : Centro de Salud Mental Il la Corredoria Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Salamanca : Centro Salud Alamedilla Unidad de Salud Mental Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Zamora : Complejo hospitalario de Zamora Updated
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Sweden
Göteborg : SU/ Affektiva 1
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Halmstad : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Kungens Kurva : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Lund : ProbarE i Lund AB
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Lund : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
View More »
Malmo : INM Psykiatrisk Mottagning
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Malmo : Ekdahl Medical AB
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Sollentuna : MSD
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)
Stockholm : Medinstructor Lippitz AB
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Uppsala : Dr. Wahlstedts mottagning
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Uppsala : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Switzerland
Basel : University Hospital Basel
General Practice Research Database Seroquel XR Safety Study
Geneva : Centre de Thérapies Breves (CTB), Secteur Jonction
EScitalopram PIndolol ONset of Action
Taiwan
Douliou City : TW003
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Kaoshiung : TW004
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
New Taipei City : TW007
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Taichung : Chung Shan Medical University Hospital
Aripiprazole for the Augmentation of Antidepressant Therapy
Tainan : TW008
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
View More »
Taipei : Taipei Veterans General Hospital
A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression
Taipei : TW005
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Taipei : TW002
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Taipei : TW006
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Taoyuan : TW001
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Thailand
Bangkok : TH002
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Chiang Mai : TH001
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Ukraine
Chernihiv District : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Dnipropetrovsk : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Dnipropetrovsk :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Dnipropetrovsk : Teva Investigational Site 181
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Donetsk : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
View More »
Donetsk :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Donetsk :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Donetsk : Teva Investigational Site 872
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Glevakha :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Kharkiv :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Kharkiv :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Kharkiv : Teva Investigational Site 282
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Kherson : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Kiev : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Kiev :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Kiev :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Kyiv : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Lugansk : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Lugansk : Teva Investigational Site 180
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Lviv : Teva Investigational Site 873
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Odesa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Odesa :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Odessa :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Odessa :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Odessa : Teva Investigational Site 875
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Poltava : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Poltava : Teva Investigational Site 183
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
s. Oleksandrivka : Teva Investigational Site 871
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Simferopol : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Uzhorod : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Village Stepanovka Kherson :
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Vinnytsya : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Vinnytsya :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Vinnytsya : Teva Investigational Site 182
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
United Kingdom
Headington : GB001
Exploratory Study of the Effects of Lu AA21004 on Cognition and Blood Oxygen Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signals in Subjects Remitted From Depression and in Controls
Horsham : ADHD Mental Health Research Unit
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Nottingham : Rushcliffe Mental Health Team
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
